MARY GONZALEZ: Open Payments
NPI 1497419865 · UVALDE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,016 in 39 payments from 21 companies in 2025. Trend: 2023 $413 · 2024 $238 · 2025 $1,016
Food & beverage: $730Education: $286
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $144 |
| Incyte Corporation | 3 | $142 |
| GlaxoSmithKline, LLC. | 5 | $101 |
| Gilead Sciences, Inc. | 1 | $93 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $61 |
| Blueprint Medicines Corporation | 2 | $57 |
| Regeneron Healthcare Solutions, Inc. | 2 | $57 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $47 |
| Agios Pharmaceuticals, Inc. | 2 | $37 |
Products named: Trodelvy, ERLEADA, AYVAKIT, TECVAYLI, NEFFY, NUCALA, MONJUVI, TRELEGY ELLIPTA.
Industry payments across TX — which companies pay providers there.
